LGC acquires Axolabs and invests in GMP manufacturing capacity for therapeutic nucleic acids

News (ZH) - Moves strengthen existing analytical and bioanalytical drug development service offering

LGC acquires leading bioanalytical sciences business from Quotient Bioresearch

News (ZH) - LGC and Quotient Bioresearch have reached an agremeent on the sale by Quotient of its Bioanalytical Sciences division to LGC.

LGC Standards extends portfolio with Cardiff Bioanalytical Services acquisition

News (ZH) - Expands proficiency testing portfolio with acquisition of specialist External Quality Assessment provider

LGC expands Fordham site to bolster Bioanalytical and CMC capacity

News (ZH) - LGC is expanding its Bioanalytical and CMC analytical services capacity at its site in Fordham, Cambridgeshire.

LGC to showcase scientific excellence at 7th EBF open meeting and 1st EBF YSS

News (ZH) - LGC’s presentations will showcase scientific excellence through research and results covering the topics of supercharging reagents, development of robust cortisol assays, carryover in the immunoassay laboratory and ultrasensitivity immunoassays

LGC launches new service for stability testing

News (ZH) - This new service enables continuous recording and monitoring of essential data on the impact of environmental factors, such as temperature and humidity, on the quality of a pharmaceutical product

Fighting the counterfeit drug war – LGC detects fake packaging using mass spectrometry

News (ZH) - LGC announces new advance in the battle to detect counterfeit drug packaging

LGC becomes first bioanalytical Contract Research Organisation to offer HD-X platform in a regulated environment

News (ZH) - The HD-X has been unveiled at LGC’s GLP/GCP-accredited lab in Fordham

LGC and Q2 Solutions announce global bioanalytical strategic partnership

News (ZH) - Will each contribute extensive experience and capabilities in small and large molecule bioanalysis to support customer-centric approach